The SGK1 Kinase Inhibitor SI113 Sensitizes Theranostic Effects of the 64CuCl2 in Human Glioblastoma Multiforme Cells

Background/Aims: The importance of copper in the metabolism of cancer cells has been widely studied in the last 20 years and a clear-cut association between copper levels and cancer deregulation has been established. Copper-64, emitting positrons and β-radiations, is indicated for the labeling of a...

Full description

Bibliographic Details
Main Authors: Giada Catalogna, Cristina Talarico, Vincenzo Dattilo, Vincenzo Gangemi, Ferdinando Calabria, Lucia D’Antona, Silvia Schenone, Francesca Musumeci, Cataldo Bianco, Nicola Perrotti, Rosario Amato, Giuseppe L. Cascini
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2017-08-01
Series:Cellular Physiology and Biochemistry
Subjects:
Online Access:http://www.karger.com/Article/FullText/480328
_version_ 1817991332268867584
author Giada Catalogna
Cristina Talarico
Vincenzo Dattilo
Vincenzo Gangemi
Ferdinando Calabria
Lucia D’Antona
Silvia Schenone
Francesca Musumeci
Cataldo Bianco
Nicola Perrotti
Rosario Amato
Giuseppe L. Cascini
author_facet Giada Catalogna
Cristina Talarico
Vincenzo Dattilo
Vincenzo Gangemi
Ferdinando Calabria
Lucia D’Antona
Silvia Schenone
Francesca Musumeci
Cataldo Bianco
Nicola Perrotti
Rosario Amato
Giuseppe L. Cascini
author_sort Giada Catalogna
collection DOAJ
description Background/Aims: The importance of copper in the metabolism of cancer cells has been widely studied in the last 20 years and a clear-cut association between copper levels and cancer deregulation has been established. Copper-64, emitting positrons and β-radiations, is indicated for the labeling of a large number of molecules suitable for radionuclide imaging as well as radionuclide therapy. Glioblastoma multiforme (GBM) is the CNS tumor with the worse prognosis, characterized by high number of recurrences and strong resistance to chemo-radio therapy, strongly affecting patients survival. We have recently discovered and studied the small molecule SI113, as inhibitor of SGK1, a serine/threonine protein kinase, that affects several neoplastic phenotypes and signaling cascades. The SI113-dependent SGK1 inhibition induces cell death, blocks proliferation, perturbs cell cycle progression and restores chemo-radio sensibility by modulating SGK1-related substrates. In the present paper we aim to characterize the combined effects of 64CuCl2 and SI113 on human GBM cell lines with variable p53 expression. Methods: Cell viability, cell death and stress/authopagic related pathways were then analyzed by FACS and WB-based assays, after exposure to SI113 and/or 64CuCl2. Results: We demonstrate here, that i) 64CuCl2 is able to induce a time and dose dependent modulation of cell viability (with different IC50 values) in highly malignant gliomas and that the co-treatment with SI113 leads to ii) additive/synergistic effects in terms of cell death; iii) enhancement of the effects of ionizing radiations, probably by a TRC1 modulation; iv) modulation of the autophagic response. Conclusions: Evidence reported here underlines the therapeutic potential of the combined treatment with SI113 and 64CuCl2 in GBM cells.
first_indexed 2024-04-14T01:11:57Z
format Article
id doaj.art-3cf5dbdeede746439b80a95cba269c45
institution Directory Open Access Journal
issn 1015-8987
1421-9778
language English
last_indexed 2024-04-14T01:11:57Z
publishDate 2017-08-01
publisher Cell Physiol Biochem Press GmbH & Co KG
record_format Article
series Cellular Physiology and Biochemistry
spelling doaj.art-3cf5dbdeede746439b80a95cba269c452022-12-22T02:21:01ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782017-08-0143110811910.1159/000480328480328The SGK1 Kinase Inhibitor SI113 Sensitizes Theranostic Effects of the 64CuCl2 in Human Glioblastoma Multiforme CellsGiada CatalognaCristina TalaricoVincenzo DattiloVincenzo GangemiFerdinando CalabriaLucia D’AntonaSilvia SchenoneFrancesca MusumeciCataldo BiancoNicola PerrottiRosario AmatoGiuseppe L. CasciniBackground/Aims: The importance of copper in the metabolism of cancer cells has been widely studied in the last 20 years and a clear-cut association between copper levels and cancer deregulation has been established. Copper-64, emitting positrons and β-radiations, is indicated for the labeling of a large number of molecules suitable for radionuclide imaging as well as radionuclide therapy. Glioblastoma multiforme (GBM) is the CNS tumor with the worse prognosis, characterized by high number of recurrences and strong resistance to chemo-radio therapy, strongly affecting patients survival. We have recently discovered and studied the small molecule SI113, as inhibitor of SGK1, a serine/threonine protein kinase, that affects several neoplastic phenotypes and signaling cascades. The SI113-dependent SGK1 inhibition induces cell death, blocks proliferation, perturbs cell cycle progression and restores chemo-radio sensibility by modulating SGK1-related substrates. In the present paper we aim to characterize the combined effects of 64CuCl2 and SI113 on human GBM cell lines with variable p53 expression. Methods: Cell viability, cell death and stress/authopagic related pathways were then analyzed by FACS and WB-based assays, after exposure to SI113 and/or 64CuCl2. Results: We demonstrate here, that i) 64CuCl2 is able to induce a time and dose dependent modulation of cell viability (with different IC50 values) in highly malignant gliomas and that the co-treatment with SI113 leads to ii) additive/synergistic effects in terms of cell death; iii) enhancement of the effects of ionizing radiations, probably by a TRC1 modulation; iv) modulation of the autophagic response. Conclusions: Evidence reported here underlines the therapeutic potential of the combined treatment with SI113 and 64CuCl2 in GBM cells.http://www.karger.com/Article/FullText/480328SGK1GBM64CuCl2SI113
spellingShingle Giada Catalogna
Cristina Talarico
Vincenzo Dattilo
Vincenzo Gangemi
Ferdinando Calabria
Lucia D’Antona
Silvia Schenone
Francesca Musumeci
Cataldo Bianco
Nicola Perrotti
Rosario Amato
Giuseppe L. Cascini
The SGK1 Kinase Inhibitor SI113 Sensitizes Theranostic Effects of the 64CuCl2 in Human Glioblastoma Multiforme Cells
Cellular Physiology and Biochemistry
SGK1
GBM
64CuCl2
SI113
title The SGK1 Kinase Inhibitor SI113 Sensitizes Theranostic Effects of the 64CuCl2 in Human Glioblastoma Multiforme Cells
title_full The SGK1 Kinase Inhibitor SI113 Sensitizes Theranostic Effects of the 64CuCl2 in Human Glioblastoma Multiforme Cells
title_fullStr The SGK1 Kinase Inhibitor SI113 Sensitizes Theranostic Effects of the 64CuCl2 in Human Glioblastoma Multiforme Cells
title_full_unstemmed The SGK1 Kinase Inhibitor SI113 Sensitizes Theranostic Effects of the 64CuCl2 in Human Glioblastoma Multiforme Cells
title_short The SGK1 Kinase Inhibitor SI113 Sensitizes Theranostic Effects of the 64CuCl2 in Human Glioblastoma Multiforme Cells
title_sort sgk1 kinase inhibitor si113 sensitizes theranostic effects of the 64cucl2 in human glioblastoma multiforme cells
topic SGK1
GBM
64CuCl2
SI113
url http://www.karger.com/Article/FullText/480328
work_keys_str_mv AT giadacatalogna thesgk1kinaseinhibitorsi113sensitizestheranosticeffectsofthe64cucl2inhumanglioblastomamultiformecells
AT cristinatalarico thesgk1kinaseinhibitorsi113sensitizestheranosticeffectsofthe64cucl2inhumanglioblastomamultiformecells
AT vincenzodattilo thesgk1kinaseinhibitorsi113sensitizestheranosticeffectsofthe64cucl2inhumanglioblastomamultiformecells
AT vincenzogangemi thesgk1kinaseinhibitorsi113sensitizestheranosticeffectsofthe64cucl2inhumanglioblastomamultiformecells
AT ferdinandocalabria thesgk1kinaseinhibitorsi113sensitizestheranosticeffectsofthe64cucl2inhumanglioblastomamultiformecells
AT luciadantona thesgk1kinaseinhibitorsi113sensitizestheranosticeffectsofthe64cucl2inhumanglioblastomamultiformecells
AT silviaschenone thesgk1kinaseinhibitorsi113sensitizestheranosticeffectsofthe64cucl2inhumanglioblastomamultiformecells
AT francescamusumeci thesgk1kinaseinhibitorsi113sensitizestheranosticeffectsofthe64cucl2inhumanglioblastomamultiformecells
AT cataldobianco thesgk1kinaseinhibitorsi113sensitizestheranosticeffectsofthe64cucl2inhumanglioblastomamultiformecells
AT nicolaperrotti thesgk1kinaseinhibitorsi113sensitizestheranosticeffectsofthe64cucl2inhumanglioblastomamultiformecells
AT rosarioamato thesgk1kinaseinhibitorsi113sensitizestheranosticeffectsofthe64cucl2inhumanglioblastomamultiformecells
AT giuseppelcascini thesgk1kinaseinhibitorsi113sensitizestheranosticeffectsofthe64cucl2inhumanglioblastomamultiformecells
AT giadacatalogna sgk1kinaseinhibitorsi113sensitizestheranosticeffectsofthe64cucl2inhumanglioblastomamultiformecells
AT cristinatalarico sgk1kinaseinhibitorsi113sensitizestheranosticeffectsofthe64cucl2inhumanglioblastomamultiformecells
AT vincenzodattilo sgk1kinaseinhibitorsi113sensitizestheranosticeffectsofthe64cucl2inhumanglioblastomamultiformecells
AT vincenzogangemi sgk1kinaseinhibitorsi113sensitizestheranosticeffectsofthe64cucl2inhumanglioblastomamultiformecells
AT ferdinandocalabria sgk1kinaseinhibitorsi113sensitizestheranosticeffectsofthe64cucl2inhumanglioblastomamultiformecells
AT luciadantona sgk1kinaseinhibitorsi113sensitizestheranosticeffectsofthe64cucl2inhumanglioblastomamultiformecells
AT silviaschenone sgk1kinaseinhibitorsi113sensitizestheranosticeffectsofthe64cucl2inhumanglioblastomamultiformecells
AT francescamusumeci sgk1kinaseinhibitorsi113sensitizestheranosticeffectsofthe64cucl2inhumanglioblastomamultiformecells
AT cataldobianco sgk1kinaseinhibitorsi113sensitizestheranosticeffectsofthe64cucl2inhumanglioblastomamultiformecells
AT nicolaperrotti sgk1kinaseinhibitorsi113sensitizestheranosticeffectsofthe64cucl2inhumanglioblastomamultiformecells
AT rosarioamato sgk1kinaseinhibitorsi113sensitizestheranosticeffectsofthe64cucl2inhumanglioblastomamultiformecells
AT giuseppelcascini sgk1kinaseinhibitorsi113sensitizestheranosticeffectsofthe64cucl2inhumanglioblastomamultiformecells